title: Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide.
authors.affiliation: Department of Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Castagna
authors.affiliation: Department of Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Bramanti
authors.affiliation: Department of Hematology, Transplantation Program Institut Paoli Calmettes, Marseille, France.
authors.forename: S
authors.initials: S
authors.lastname: Furst
authors.affiliation: Statistic Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Giordano
authors.affiliation: Department of Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Sarina
authors.affiliation: Department of Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Crocchiolo
authors.forename: J
authors.initials: J
authors.lastname: El-Cheikh
authors.affiliation: Department of Hematology, Transplantation Program Institut Paoli Calmettes, Marseille, France.
authors.forename: J El
authors.initials: JE
authors.lastname: Cheikh
authors.affiliation: Department of Hematology, Transplantation Program Institut Paoli Calmettes, Marseille, France.
authors.forename: A
authors.initials: A
authors.lastname: Granata
authors.affiliation: Department of Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Morabito
authors.affiliation: Department of Hematology, Ospedale Ferrarotto, Catania, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Mauro
authors.affiliation: Department of Hematology, Transplantation Program Institut Paoli Calmettes, Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Faucher
authors.affiliation: Department of Hematology, Transplantation Program Institut Paoli Calmettes, Marseille, France.
authors.forename: B
authors.initials: B
authors.lastname: Mohty
authors.affiliation: Department of Hematology, Transplantation Program Institut Paoli Calmettes, Marseille, France.
authors.forename: S
authors.initials: S
authors.lastname: Harbi
authors.affiliation: Department of Hematology, Transplantation Program Institut Paoli Calmettes, Marseille, France.
authors.forename: R
authors.initials: R
authors.lastname: Devillier
authors.affiliation: Cell Therapy Unit Institut Paoli Calmettes, Marseille, France.|Aix-Marseille Université, Marseille, France.|Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Chabannon
authors.affiliation: Department of Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Carlo-Stella
authors.affiliation: Department of Hematology, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Santoro
authors.affiliation: Department of Hematology, Transplantation Program Institut Paoli Calmettes, Marseille, France.|Aix-Marseille Université, Marseille, France.|Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France.
authors.forename: D
authors.initials: D
authors.lastname: Blaise
mesh_terms: D000328:Adult; D064591:Allografts; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D016572:Cyclosporine; D003520:Cyclophosphamide; D016559:Tacrolimus